3D structures of two rye pollen molecules resolved after 30-year search, opening immunology research avenues
Researchers have determined the precise three-dimensional structures of two natural compounds from rye pollen that showed anti-tumour activity in earlier animal studies, providing a molecular blueprint for further investigation.
A study reported by ScienceDaily describes the resolution of a structural biology puzzle that had remained open for approximately 30 years. Two unusual molecules found in rye pollen, which previously demonstrated an ability to affect tumour growth in animal models, have had their exact three-dimensional structures determined. According to the report, the structural data provide a blueprint that researchers can now use to investigate how the compounds interact with the immune system and to identify which molecular substructures may underlie the observed biological activity.
The ScienceDaily summary does not specify the lead institution, primary authors, or journal of publication. Readers wishing to examine the methodology and full data should seek the primary paper. The relevance to cancer research is described as investigational: the compounds' effects have been observed in animal studies, and the structural work is a step towards understanding the underlying mechanism rather than a demonstration of therapeutic application in humans.
For researchers in chemical biology, structural genomics, and cancer immunology, the finding is of interest because it exemplifies how advances in structural determination techniques — likely cryo-electron microscopy or X-ray crystallography, though this is not confirmed in the available summary — can reopen longstanding questions about natural-product biology. The work has potential relevance for future mechanistic and drug-discovery research rather than near-term clinical translation.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source ScienceDaily · 2026-07-06Scientists solve a 30-year rye pollen mystery that could transform cancer research